Topics
Glioblastoma | Treatment | Immunotherapy | Patient selection
Home > Publications > Topics > Glioblastoma > Treatment > Immunotherapy > Patient selection
Losurdo A, Dipasquale A,
Giordano L, Persico P, Lorenzi E, Di Muzio A, Barigazzi C,
Korolewicz J, Mehan A, Mohammed O, Scheiner B, Pinato DJ, Santoro
A, Simonelli M.
Refining
patient selection for next-generation immunotherapeutic
early-phase clinical trials with a novel and externally validated
prognostic nomogram.
Front
Immunol.
2024 Jan 15;15:1323151. doi:
10.3389/fimmu.2024.1323151. PMID:
38298193. Observational study. ˍ